Jacqueline Acquah is a registered pharmacist in Ghana and holds an MPH from the University of Ghana.

Jacqueline has over 16 years of experience in healthcare, with a significant number of those years being in regulatory affairs.

She previously worked for Johnson & Johnson as an Associate Director responsible for vaccines regulatory affairs in emerging markets in Eastern Europe, Middle East, and Africa (EMEA). There, she was instrumental in developing strategies in obtaining Emergency Use and Marketing authorizations to potentiate access to J&J vaccines in over 50 LMICs, particularly COVID-19 vaccines, during the COVID-19 pandemic. She was also instrumental in working with the WHO/AVAREF, Africa Vaccines Regulatory Forum during the COVID-19 pandemic, to shape the regulatory ecosystem for emergency use authorizations.

Jacqueline also served as Co-Chair for the Africa Regulatory Network (ARN) of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and was a member of IFPMA’s Regulatory Science Committee (RSC), the highest regulatory decision-making body of the IFPMA. Together with other industry colleagues, she led the association to work in collaboration with regulatory authorities and the pharmaceutical industry in Africa to encourage greater harmonization of regulatory requirements on the African continent and strengthening of the regulatory ecosystem.

Through the IFPMA, she has supported the work of the AMRH since 2018, sitting on various TCs and contributing to regulatory harmonization on the continent.

Prior to joining J&J, Jacqueline worked with Pfizer, leading corporate regulatory strategy in West and Central Africa.

Jacqueline has also previously worked the 37 Military Hospital and the Pharmaceutical Society of Ghana. Jacqueline has contributed to several regulatory publications on Africa and spoken at various international regulatory affairs fora.